- •Vascular Surgery
- •SECTION AND BOARD OF VASCULAR SURGERY
- •Foreword to the First Edition
- •Preface to the First Edition
- •Preface to the Second Edition
- •Preface to the Third Edition
- •Contents
- •Contributors
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •1.1 Commentary
- •1.2 Beta-Adrenergic Antagonists
- •1.3 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (Statins)
- •1.4 Percutaneous Revascularization
- •1.5 Coronary Artery Bypass Grafting
- •References
- •2: Abdominal Aortic Aneurysm
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •2.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •Question 11
- •Question 12
- •Question 13
- •Question 14
- •3.1 Commentary
- •3.2 Case Analysis Quiz
- •References
- •4: Ruptured Abdominal Aortic Aneurysm
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •4.1 Commentary
- •References
- •5: Thoracoabdominal Aortic Aneurysm
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •5.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •Question 11
- •Question 12
- •Question 13
- •6.1 Commentary
- •References
- •7: Aortic Dissection
- •7.1 Dissection: Stanford A
- •Question 1
- •Question 2
- •Question 3
- •7.2 Dissection: Stanford B
- •Question 4
- •Question 5
- •7.3 Commentary
- •References
- •8: Popliteal Artery Aneurysms
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •8.1 Popliteal Artery Aneurysm
- •References
- •9: Renal Artery Aneurysm
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •9.1 Commentary
- •References
- •10: Anastomotic Aneurysms
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •10.1 Commentary
- •10.2 Indications for Intervention
- •10.3 Treatment for Anastomotic Aneurysms
- •10.4 Infection in Anastomotic Aneurysms
- •10.5 Outcome
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •11.1 Commentary
- •References
- •12: Acute Thrombosis
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •12.1 Commentary
- •References
- •13: Arterial Embolism
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •13.1 Commentary
- •References
- •14: Blast Injury to the Lower Limb
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •14.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •15.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Smoking
- •Antiplatelet Agents
- •Blood Pressure (BP)
- •Glucose Status
- •Lipids
- •Emerging Risk Factors
- •Question 4
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •Question 11
- •17.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •18.1 Commentary
- •18.2 Clinical Assessment
- •18.3 Imaging Techniques
- •18.4 Revascularization Options
- •18.5 Aortobifemoral Bypass
- •18.6 Iliac Angioplasty and Stenting
- •18.7 Iliac Stenting Combined with Profunda Femoris Artery Revascularization
- •18.8 Rationale for Angioplasty of “Donor” Iliac Artery Prior to Femorofemoral Crossover Bypass
- •18.10 Supervision and Follow-up of the Patient
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •Question 11
- •Question 12
- •19.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •20.1 Commentary
- •References
- •21: Bypass to the Popliteal Artery
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •21.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •22.1 Commentary
- •References
- •23: Popliteal Artery Entrapment
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •23.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •24.1 Commentary
- •References
- •25: The Obturator Foramen Bypass
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •25.1 Commentary
- •25.2 Preoperative Measures
- •25.3 The Concept of the Obturator Foramen Bypass
- •25.4 Obturator Foramen Bypass Technique
- •References
- •26: Diabetic Foot
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •Question 11
- •26.1 Commentary
- •References
- •27: Chronic Visceral Ischemia
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •27.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •28.1 Commentary
- •References
- •29: Renovascular Hypertension
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •29.1 Commentary
- •29.4 Intra-arterial Angiography
- •29.5 Duplex Ultrasonography (DU)
- •29.6 Treatment
- •29.6.1 Medical Treatment
- •29.6.2 Revascularization
- •29.7 Prognosis
- •References
- •30: Midaortic Syndrome
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •30.1 Commentary
- •References
- •31: Management of Portal Hypertension
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •31.1 Commentary
- •31.2 General Considerations
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •32.1 Commentary
- •References
- •33: The Carotid Body Tumor
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •33.1 Commentary
- •33.2 Clinical Presentation
- •33.3 Treatment
- •33.4 Summary
- •References
- •Question 1
- •Question 2
- •Question 3
- •34.1 Commentary
- •34.2 Vertebrobasilar Ischemia: Low-Flow Mechanism
- •Question 1
- •Question 2
- •34.3 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •35.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •36.1 Commentary
- •References
- •37: Acute Axillary/Subclavian Vein Thrombosis
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •37.1 Commentary
- •References
- •38: Raynaud’s Phenomenon
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •38.1 Commentary
- •References
- •39: Aortofemoral Graft Infection
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •39.1 Commentary
- •References
- •40: Aortoenteric Fistulas
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •40.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •41.1 Commentary
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Questions 7 and 8
- •Question 9
- •Question 10
- •Comment
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •42.1 Commentary
- •References
- •43: Amputations in an Ischemic Limb
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •43.1 Commentary
- •References
- •44: Congenital Vascular Malformation
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •44.1 Clinical Evaluation
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •Question 11
- •44.2 Commentary
- •References
- •45: Klippel-Trenaunay Syndrome
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •45.1 Commentary
- •Clinical Presentation
- •Evaluation
- •Treatment
- •References
- •46: Deep Venous Thrombosis
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •46.1 Commentary
- •References
- •47: Endoluminal Ablation of Varicose Veins
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •47.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •48.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •50.1 Commentary
- •References
- •51: Iliofemoral Venous Thrombosis
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •50.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •Question 11
- •52.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •Question 6
- •Question 7
- •Question 8
- •Question 9
- •Question 10
- •53.1 Commentary
- •References
- •Question 1
- •Question 2
- •Question 3
- •Question 4
- •Question 5
- •54.1 Commentary
- •References
- •Index
|
|
Endoluminal Ablation of Varicose Veins |
47 |
|
|
Cassius Iyad N. Ochoa Chaar and Jeffrey Indes |
|
|
|
A 48-year-old male was referred by his primary care physician (PCP) for evaluation of varicose veins (VV) in his right leg. The patient noted the varicosities in his twenties. Initially, he was not concerned with the cosmetic appearance and decided not to seek medical attention. The VV became progressively more prominent. He started to complain of right leg pain and fatigue associated with mild edema 6 months prior to referral. The pain increased during the day and was unbearable in the evening after work. The patient works as a barber and needs to stand most of the day. His past medicalhistoryissignificantforamotorvehicleaccident10yearsago.Heonlytakes NSAIDs occasionally to relieve his leg pain. The patient finally decided to seek medical attention. His primary care physician prescribed him compression stockings that he used for 3 months with minimal improvement.
Question 1
At this point, what other information would you like to obtain?
A. What where the circumstances of the motor vehicle accident? B. Does the patient have family history of VV?
C. Was the diagnosis of deep vein thrombosis (DVT) entertained by the PCP and was there any duplex ultrasound (DU) performed?
D. Was the patient compliant with the compression stocking, and did he wear the appropriate stocking?
The patient recalled the car accident. He was a front seat passenger and the car was hit on his side at a moderate speed. He remembers receiving a CT scan. The doctors told him his only injury was a rib fracture on the right side. He did not require hospitalization and was ambulating the same day. The patienthas two sisterswith VV thatwerefirstnoticedduring
C.I.N.O. Chaar ( )
General Surgery Department, Yale New Haven Hospital, New Haven, CT, USA
G. Geroulakos and B. Sumpio (eds.), Vascular Surgery, |
491 |
DOI: 10.1007/978-1-84996-356-5_47, © Springer-Verlag London Limited 2011 |
|
492 |
C.I.N.O. Chaar and J. Indes |
|
|
pregnancy but did not require surgical intervention. He denies receiving an ultrasound recently. He shows you the compression stockings which were fitted by the same company you routinely refer your patients to. He tells you:
I wear those socks as soon as I wake up in the morning and take them off before sleeping.
Question 2
Which statement(s) is/are true regarding VV?
A. VV are extremely common and are present in 90% of the population. B. Risk factors are age, female sex hormones, and hereditary.
C. Most patients present because of leg pain.
D. Venous ulcers typically occur over the metatarsal heads and other weight baring spots in the foot.
Question 3
Which of the following statement(s) is/are true regarding compression stockings?
A. Stockings decrease venous reflux and leg swelling but increase veno-muscular efficiency. B. Prescription of stockings is classified according to the pressure level required – Class 1
stockings exert the least sub-bandage pressure (14–21 mmHg).
C. The classification of compression stockings is internationally standardized.
D. The application of compression stockings is safe and has no reported complications. E. The treatment of VV with compression stockings as first line modality is supported by
level 1 evidence.
You examine the patient and you notice significant dilatation along the antero-medial aspect of the right thigh and leg as shown in Fig. 47.1. There is no ulceration or pigmentation. The left leg is normal.
Question 4
How would you like to proceed with the evaluation? What information would you like to obtain?
A. Hand held Doppler can help to assess reflux. B. DU will provide most of the information needed. C. Rule out the presence of a DVT.
D. Assess saphenofemoral junction (SFJ) and sapheno-popliteal junction (SPJ) for reflux. E. Look for incompetent perforators.
You obtain a DU that does not show evidence of DVT. There is reflux only at the SFJ without the presence of incompetent perforators.
47 Endoluminal Ablation of Varicose Veins |
493 |
|
|
Fig. 47.1 Patient’s right leg with VV upon presentation
Question 5
What treatment options can you offer to the patient?
A. High Ligation and Stripping
B. Endovenous laser therapy (EVLT)
C. Endovenous radiofrequency ablation (RFA)
Initially the patient asks you to explain to him what would be the most conservative treatment modality. He has a conservative mentality and does not want to “try anything new.”
Question 6
The True statement(s) about high ligation and stripping is (are):
A. High ligation without stripping predisposes patient to recurrence.
B. High ligation and stripping of the small saphenous vein (SSV) is associated with a higher rate of complications as compared with high ligation alone.
494 |
C.I.N.O. Chaar and J. Indes |
|
|
C. High ligation and stripping is no longer the gold standard of treatment of VV after the introduction of endoluminal therapy.
D. The improvement in quality of life with VV surgery is comparable to the improvement that patients with billiary colic get after laparoscopic cholecystectomy.
After explaining what an open procedure entails, you explain to the patient the different endoluminal options. He finds endoluminal treatment appealing and elects to proceed with EVLT. After obtaining informed consent, the patient’s right leg is prepped and draped sterile. The patient is initially positioned in reverse Trendelenburg and venous access is obtained in the greater saphenous vein (GSV) just below the knee with a 4F micropuncture set. The micropuncture sheath is replaced with the long 5F sheath and the laser fiber is exposed and positioned at 2.0 cm below the SFJ and 1.55 cm below the superficial epigastric vein (SEV) under ultrasound guidance (Fig. 47.2).
The patient is then positioned in Trendelenburg and 500cc of tumescent anesthesia are administered around the GSV. The power is set at 14J and the treatment starts while simultaneously pulling back on the sheath and the laser probe at 1 cm every 5 s. You examine the vein with DU and find it devoid of flow with evidence of thrombosis of the entire treatment length. The absence of extension of thrombosis into the superficial femoral vein through the SFJisconfirmed.ThereisnoevidenceofDVTwithgoodflowobservedwithinthecommon femoral vein. In addition, the very proximal GSV and SEV have evidence of flow proximal to the ablated segment. An ACE wrap is applied to the right lower extremity for two days. The patient is recommended to continue using compression stockings for one month.
Question 7
Which statement(s) is/are true about tumescent anesthesia?
A. It is a unique type of anesthesia used only with EVLT.
B. It is administered around the vein and helps prevent conduction of heat to surrounding tissue.
Fig. 47.2 DU showing the tip of the probe in the GSV (arrow) positioned at 1.55 cm distal to the Superficial Epigastric Vein (SEV)